Search Results - "Stalpers, L J"

Refine Results
  1. 1

    The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies by van Leeuwen, C M, Oei, A L, Crezee, J, Bel, A, Franken, N A P, Stalpers, L J A, Kok, H P

    Published in Radiation oncology (London, England) (16-05-2018)
    “…Prediction of radiobiological response is a major challenge in radiotherapy. Of several radiobiological models, the linear-quadratic (LQ) model has been best…”
    Get full text
    Journal Article
  2. 2

    How can communication by oncologists enhance patients' trust? An experimental study by Hillen, M.A., de Haes, H.C.J.M., Stalpers, L.J.A., Klinkenbijl, J.H.G., Eddes, E.H., Butow, P.N., van der Vloodt, J., van Laarhoven, H.W.M., Smets, E.M.A.

    Published in Annals of oncology (01-04-2014)
    “…Cancer patients need to trust their oncologist to embark in the process of oncologic treatment. Yet, it is unclear how oncologist communication contributes to…”
    Get full text
    Journal Article
  3. 3

    Dosimetric comparison of library of plans and online MRI-guided radiotherapy of cervical cancer in the presence of intrafraction anatomical changes by Visser, J, de Boer, P, Crama, K F, van Kesteren, Z, Rasch, C R N, Stalpers, L J A, Bel, A

    Published in Radiation oncology (London, England) (12-07-2019)
    “…Online magnetic resonance imaging (MRI)-guided radiotherapy of cervical cancer has the potential to further reduce dose to organs at risk (OAR) as compared to…”
    Get full text
    Journal Article
  4. 4

    Late neurocognitive sequelae in patients with WHO grade I meningioma by Dijkstra, M, van Nieuwenhuizen, D, Stalpers, L J A, Wumkes, M, Waagemans, M, Vandertop, W P, Heimans, J J, Leenstra, S, Dirven, C M, Reijneveld, J C, Klein, M

    “…Background:Information on neurocognitive outcome following treatment of benign meningiomas is virtually lacking. This is remarkable considering that survival…”
    Get full text
    Journal Article
  5. 5

    Bevacizumab and dose-intense temozolomide in recurrent high-grade glioma by Verhoeff, J.J.C., Lavini, C., van Linde, M.E., Stalpers, L.J.A., Majoie, C.B.L.M., Reijneveld, J.C., van Furth, W.R., Richel, D.J.

    Published in Annals of oncology (01-08-2010)
    “…Angiogenesis inhibition is a rational treatment strategy for high-grade glioma (HGG). Combined antiangiogenic therapy and chemotherapy could be beneficial,…”
    Get full text
    Journal Article
  6. 6

    Biological modelling of the radiation dose escalation effect of regional hyperthermia in cervical cancer by Crezee, J, van Leeuwen, C M, Oei, A L, van Heerden, L E, Bel, A, Stalpers, L J A, Ghadjar, P, Franken, N A P, Kok, H P

    Published in Radiation oncology (London, England) (02-02-2016)
    “…Locoregional hyperthermia combined with radiotherapy significantly improves locoregional control and overall survival for cervical tumors compared to…”
    Get full text
    Journal Article
  7. 7

    Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomide by van Nifterik, K A, van den Berg, J, van der Meide, W F, Ameziane, N, Wedekind, L E, Steenbergen, R D M, Leenstra, S, Lafleur, M V M, Slotman, B J, Stalpers, L J A, Sminia, P

    Published in British journal of cancer (29-06-2010)
    “…Background: The DNA repair protein O 6 -methylguanine-DNA methyltransferase (MGMT) can cause resistance to the alkylating drug temozolomide (TMZ). The purpose…”
    Get full text
    Journal Article
  8. 8

    Molecular and biological rationale of hyperthermia as radio- and chemosensitizer by Oei, A.L., Kok, H.P., Oei, S.B., Horsman, M.R., Stalpers, L.J.A., Franken, N.A.P., Crezee, J.

    Published in Advanced drug delivery reviews (2020)
    “…Mild hyperthermia, local heating of the tumour up to temperatures <43 °C, has been clinically applied for almost four decades and has been proven to…”
    Get full text
    Journal Article
  9. 9

    Radiation-enhanced vascular endothelial growth factor (VEGF) secretion in glioblastoma multiforme cell lines : a clue to radioresistance? by HOVINGA, K. E, STALPERS, L. J. A, VAN BREE, C, DONKER, M, VERHOEFF, J. J. C, RODERMOND, H. M, BOSCH, D. A, VAN FURTH, W. R

    Published in Journal of neuro-oncology (01-09-2005)
    “…Postoperative radiotherapy is standard treatment for patients with a glioblastoma multiforme (GBM). However, a GBM is radioresistant and almost always recurs,…”
    Get full text
    Journal Article
  10. 10

    Cisplatin-DNA adduct formation in patients treated with cisplatin-based chemoradiation: lack of correlation between normal tissues and primary tumor by Hoebers, F. J. P., Pluim, D., Hart, A. A. M., Verheij, M., Balm, A. J. M., Fons, G., Rasch, C. R. N., Schellens, J. H. M., Stalpers, L. J. A., Bartelink, H., Begg, A. C.

    Published in Cancer chemotherapy and pharmacology (01-05-2008)
    “…Purpose In this study, the formation of cisplatin-DNA adducts after concurrent cisplatin-radiation and the relationship between adduct-formation in primary…”
    Get full text
    Journal Article
  11. 11

    [ 18 F]FDG-PET/CT-based risk stratification in women with locally advanced uterine cervical cancer by Adam, J A, Poel, E, van Eck Smit, B L F, Mom, C H, Stalpers, L J A, Laan, J J, Kidd, E, Stoker, J, Bipat, S

    Published in BMC cancer (23-04-2024)
    “…[ F]FDG-PET/CT is used for staging and treatment planning in patients with locally advanced cervical cancer (LACC). We studied if a PET-based prediction model…”
    Get full text
    Journal Article
  12. 12

    The effect of time interval between radiotherapy and hyperthermia on planned equivalent radiation dose by van Leeuwen, C M, Crezee, J, Oei, A L, Franken, N A P, Stalpers, L J A, Bel, A, Kok, H P

    Published in International journal of hyperthermia (03-10-2018)
    “…Thermoradiotherapy is an effective treatment for locally advanced cervical cancer. However, the optimal time interval between radiotherapy and hyperthermia,…”
    Get more information
    Journal Article
  13. 13

    Feasibility of on-line temperature-based hyperthermia treatment planning to improve tumour temperatures during locoregional hyperthermia by Kok, H P, Korshuize-van Straten, L, Bakker, A, de Kroon-Oldenhof, R, Westerveld, G H, Versteijne, E, Stalpers, L J A, Crezee, J

    Published in International journal of hyperthermia (03-10-2018)
    “…The effectiveness of hyperthermia is strongly dependent on the achieved tumour temperatures. Phased-array systems allow flexible power steering to realise good…”
    Get more information
    Journal Article
  14. 14

    Measurement and analysis of the impact of time-interval, temperature and radiation dose on tumour cell survival and its application in thermoradiotherapy plan evaluation by van Leeuwen, C M, Oei, A L, Ten Cate, R, Franken, N A P, Bel, A, Stalpers, L J A, Crezee, J, Kok, H P

    Published in International journal of hyperthermia (02-01-2018)
    “…Biological modelling of thermoradiotherapy may further improve patient selection and treatment plan optimisation, but requires a model that describes the…”
    Get more information
    Journal Article
  15. 15

    On verification of hyperthermia treatment planning for cervical carcinoma patients by van Haaren, P M A, Kok, H P, van den Berg, C A T, Zum Vörde Sive Vörding, P J, Oldenborg, S, Stalpers, L J A, Schilthuis, M S, de Leeuw, A A C, Crezee, J

    “…The aim of this study was to verify hyperthermia treatment planning calculations by means of measurements performed during hyperthermia treatments. The…”
    Get more information
    Journal Article
  16. 16

    Socioeconomic status as an independent risk factor for severe late bowel toxicity after primary radiotherapy for cervical cancer by Laan, J.J., van Lonkhuijzen, L.R.C.W., van Os, R.M., Tytgat, K.M., Dávila Fajardo, R., Pieters, B.R., Stalpers, L.J.A., Westerveld, G.H.

    Published in Gynecologic oncology (01-12-2017)
    “…•1/8 women develop severe late bowel toxicity after radiotherapy for cervical cancer.•Severe late bowel toxicity occurs mostly within the first 3years after…”
    Get full text
    Journal Article
  17. 17

    Long-term cervical cancer survivors suffer from pelvic floor symptoms: A cross-sectional matched cohort study by Hazewinkel, M.H, Sprangers, M.A.G, van der Velden, J, van der Vaart, C.H, Stalpers, L.J.A, Burger, M.P.M, Roovers, J.P.W.R

    Published in Gynecologic oncology (01-05-2010)
    “…Abstract Objective The aim of this study was to determine prevalence of and experienced distress from pelvic floor symptoms in cervical cancer survivors (CCS)…”
    Get full text
    Journal Article
  18. 18

    Repair of Potentially Lethal Damage does not Depend on Functional TP53 in Human Glioblastoma Cells by van Bree, C., Franken, N. A P., Rodermond, H. M., Stalpers, L. J A., Haveman, J.

    Published in Radiation research (01-05-2004)
    “…van Bree, C., Franken, N. A. P., Rodermond, H. M., Stalpers, L. J. A. and Haveman, J. Repair of Potentially Lethal Damage does not Depend on Functional TP53 in…”
    Get full text
    Journal Article
  19. 19

    Generic method for automatic bladder segmentation on cone beam CT using a patient-specific bladder shape model by van de Schoot, A. J. A. J., Schooneveldt, G., Wognum, S., Hoogeman, M. S., Chai, X., Stalpers, L. J. A., Rasch, C. R. N., Bel, A.

    Published in Medical physics (Lancaster) (01-03-2014)
    “…Purpose: The aim of this study is to develop and validate a generic method for automatic bladder segmentation on cone beam computed tomography (CBCT),…”
    Get full text
    Journal Article
  20. 20

    Postoperative single-dose interstitial high–dose-rate brachytherapy in therapy-resistant keloids by Hafkamp, C.J.H, Lapid, O, Dávila Fajardo, R, van de Kar, A.L, Koedooder, C, Stalpers, L.J, Pieters, B.R

    Published in Brachytherapy (01-03-2017)
    “…Abstract Purpose Patients with keloids complain of the cosmetic aspect, pain, and pruritus. Many different therapies are being used for keloids. The aim of…”
    Get full text
    Journal Article